- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 5/027 - Peptides having up to four amino acids in a fully defined sequenceDerivatives thereof containing at least one abnormal peptide link in which at least a gamma-amino acid is involved, e.g. statine
Patent holdings for IPC class C07K 5/027
Total number of patents in this class: 95
10-year publication summary
|
4
|
2
|
1
|
3
|
3
|
1
|
2
|
3
|
5
|
5
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Zymeworks Inc. | 263 |
8 |
| SeaGen Inc | 594 |
6 |
| Ontario Institute for Cancer Research (oicr) | 83 |
3 |
| Pfizer Inc. | 3403 |
2 |
| Toray Industries, Inc. | 7006 |
2 |
| Exelixis, Inc. | 394 |
2 |
| Regeneron Pharmaceuticals, Inc. | 4417 |
2 |
| Bicyclerd Limited | 148 |
2 |
| Jiangsu Mabwell Health Pharmaceutical R&D Co., Ltd. | 19 |
2 |
| Mabwell (Shanghai) Bioscience Co., Ltd. | 74 |
2 |
| Levena Biopharma Co., Ltd. | 8 |
2 |
| Mabplex International Co., Ltd. | 18 |
2 |
| Novartis AG | 10635 |
1 |
| Genentech, Inc. | 4006 |
1 |
| Centre National de La Recherche Scientifique | 10645 |
1 |
| Ajinomoto Co., Inc. | 2306 |
1 |
| Acure Pharma AB | 3 |
1 |
| Adaerata, Limited Partnership | 27 |
1 |
| Ambrx, Inc. | 180 |
1 |
| Amorchem Holdings Inc. | 2 |
1 |
| Other owners | 52 |